Upregulating the expression of SIRT1 in the PVN of SHRs reduces NF-κB p65 activity, inhibits inflammasome formation, thereby weakening sympathetic nervous activity, and alleviating hypertension. Here, SIRT1 is linked to hypertensive disorder.